Switch theme
Sign up to access all valuation multiples
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
2005
2.1K+
LTM Revenue $439M
LTM EBITDA $53.3M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Phreesia has a last 12-month revenue (LTM) of $439M and a last 12-month EBITDA of $53.3M.
In the most recent fiscal year, Phreesia achieved revenue of $420M and an EBITDA of -$25.6M.
Phreesia expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Phreesia valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $439M | XXX | $420M | XXX | XXX | XXX |
| Gross Profit | $369M | XXX | $285M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $53.3M | XXX | -$25.6M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | -6% | XXX | XXX | XXX |
| EBIT | -$42.0M | XXX | -$58.1M | XXX | XXX | XXX |
| EBIT Margin | -10% | XXX | -14% | XXX | XXX | XXX |
| Net Profit | -$43.4M | XXX | -$58.5M | XXX | XXX | XXX |
| Net Margin | -10% | XXX | -14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Phreesia's stock price is $24.
Phreesia has current market cap of $1.5B, and EV of $1.4B.
See Phreesia trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.5B | XXX | XXX | XXX | XXX | $-0.74 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Phreesia has market cap of $1.5B and EV of $1.4B.
Phreesia's trades at 3.3x EV/Revenue multiple, and -43.0x EV/EBITDA.
Equity research analysts estimate Phreesia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Phreesia has a P/E ratio of -33.6x.
See valuation multiples for Phreesia and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | 25.9x | XXX | -43.0x | XXX | XXX | XXX |
| EV/EBIT | -32.9x | XXX | -21.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -33.6x | XXX | -22.4x | XXX | XXX | XXX |
| EV/FCF | 62.6x | XXX | 491.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPhreesia's last 12 month revenue growth is 13%
Phreesia's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Phreesia's rule of 40 is 5% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Phreesia's rule of X is 44% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Phreesia and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | -8% | XXX | XXX | XXX |
| EBITDA Growth | 80% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 5% | XXX | 5% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 82% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Phreesia acquired XXX companies to date.
Last acquisition by Phreesia was XXXXXXXX, XXXXX XXXXX XXXXXX . Phreesia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Phreesia founded? | Phreesia was founded in 2005. |
| Where is Phreesia headquartered? | Phreesia is headquartered in United States of America. |
| How many employees does Phreesia have? | As of today, Phreesia has 2.1K+ employees. |
| Who is the CEO of Phreesia? | Phreesia's CEO is Mr. Chaim Indig. |
| Is Phreesia publicy listed? | Yes, Phreesia is a public company listed on NYS. |
| What is the stock symbol of Phreesia? | Phreesia trades under PHR ticker. |
| When did Phreesia go public? | Phreesia went public in 2019. |
| Who are competitors of Phreesia? | Similar companies to Phreesia include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Phreesia? | Phreesia's current market cap is $1.5B |
| What is the current revenue of Phreesia? | Phreesia's last 12 months revenue is $439M. |
| What is the current revenue growth of Phreesia? | Phreesia revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Phreesia? | Current revenue multiple of Phreesia is 3.2x. |
| Is Phreesia profitable? | Yes, Phreesia is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Phreesia? | Phreesia's last 12 months EBITDA is $53.3M. |
| What is Phreesia's EBITDA margin? | Phreesia's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Phreesia? | Current EBITDA multiple of Phreesia is 25.9x. |
| What is the current FCF of Phreesia? | Phreesia's last 12 months FCF is $22.1M. |
| What is Phreesia's FCF margin? | Phreesia's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Phreesia? | Current FCF multiple of Phreesia is 62.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
